Katharina G. Mcfarland Sells 3,996 Shares of Transphorm, Inc. (NASDAQ:TGAN) Stock

Transphorm, Inc. (NASDAQ:TGAN) Director Katharina G. Mcfarland sold 3,996 shares of Transphorm stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $4.89, for a total transaction of $19,540.44. Following the transaction, the director now directly owns 81,323 shares of the company’s stock, valued at $397,669.47. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Transphorm Price Performance

Transphorm stock remained flat at $4.89 during trading hours on Friday. 88,004 shares of the company’s stock traded hands, compared to its average volume of 173,947. Transphorm, Inc. has a 1 year low of $1.94 and a 1 year high of $4.96. The stock has a 50 day moving average of $4.88 and a 200-day moving average of $4.31. The stock has a market capitalization of $302.98 million, a PE ratio of -7.09 and a beta of 0.59.

Transphorm (NASDAQ:TGAN) last released its quarterly earnings results on Tuesday, February 20th. The company reported ($0.20) earnings per share (EPS) for the quarter. The business had revenue of $4.67 million during the quarter. Transphorm had a negative net margin of 177.91% and a negative return on equity of 149.03%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. AIGH Capital Management LLC raised its position in shares of Transphorm by 4.7% during the third quarter. AIGH Capital Management LLC now owns 4,619,558 shares of the company’s stock worth $10,255,000 after acquiring an additional 206,965 shares during the last quarter. Vanguard Group Inc. lifted its position in Transphorm by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 1,500,305 shares of the company’s stock valued at $7,366,000 after purchasing an additional 19,986 shares during the period. Worth Venture Partners LLC boosted its stake in shares of Transphorm by 4.6% in the 3rd quarter. Worth Venture Partners LLC now owns 1,152,278 shares of the company’s stock valued at $2,558,000 after purchasing an additional 50,598 shares during the last quarter. Gabelli Funds LLC acquired a new stake in shares of Transphorm during the 1st quarter worth approximately $1,395,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in shares of Transphorm during the first quarter worth approximately $1,147,000. Institutional investors and hedge funds own 66.45% of the company’s stock.

About Transphorm

Transphorm, Inc, a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages.